Dr. Clinton Gabriel Keilman, MD

Dr. Keilman practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Keilman's NPI, 1619031267, was assigned on December 20, 2006. Dr. Keilman graduated from Sidney Kimmel Medical College in 2003. Dr. Keilman holds Florida license ME128366.

Dr. Keilman's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Keilman's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dr. Keilman is also affiliated with AdventHealth Tampa. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Keilman to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keilman practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Keilman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Keilman is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Keilman's licenses on file in 4 states: Florida, North Carolina, Virginia and Georgia.

CMS data shows 189 Medicare services from Dr. Keilman across 5 procedure codes in 2024, all of them office visits, for 185 Medicare patients. Medicare paid $15,119 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 185 Medicare patients who saw Dr. Keilman in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keilman's median patient age at 66, with 51% women.

In 2024, Dr. Keilman wrote 122 Medicare Part D claims for 91 patients. 93% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $92 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

Dr. Keilman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Keilman in 2005.

CMS Open Payments shows 5 general payments to Dr. Keilman from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $131.

Dr. Keilman graduated from Sidney Kimmel Medical College in 2003.

Dr. Keilman is in network with 5 carriers, including Humana, United Healthcare and Alliant Health Plans. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.